Overview A Study Comparing Tazarotene Cream 0.1% to Tazorac® and Both to a Placebo Control in the Treatment of Acne Vulgaris Status: Completed Trial end date: 2015-02-01 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate the therapeutic equivalence and safety of Tazarotene Cream 0.1% and Tazorac® (tazarotene cream 0.1%). Phase: Phase 1 Details Lead Sponsor: Taro Pharmaceuticals USATreatments: Nicotinic AcidsTazarotene